Meeting
2015 ASCO Annual Meeting
Clinical implementation of anchored multiplex PCR with targeted next-generation sequencing for detection of ALK, ROS1, RET and NTRK1 fusions in non-small cell lung carcinoma.
Authors
Anna F. Farago
Massachusetts General Hospital, Boston, MA
Anna F. Farago , Zongli Zheng , Alona Muzikansky , Justin F. Gainor , A. John Iafrate , Jeffrey A. Engelman , Long P. Le , Alice Tsang Shaw
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 8095)
DOI
10.1200/jco.2015.33.15_suppl.8095
Abstract #
8095
Poster Bd #
419
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Genomic characterization and outcome evaluation of kinome fusions in a large non-small cell lung cancer population.
First Author: Fengying Wu
Poster
2018 ASCO Annual Meeting
An amplicon-based liquid biopsy for detecting ALK and ROS1 fusions and resistance mutations in advanced non-small cell lung cancer (NSCLC) patients.
First Author: Laura Mezquita
Poster
2023 ASCO Annual Meeting
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction (PCR) versus next-generation sequencing (NGS) testing strategies in metastatic non-small cell lung cancer (mNSCLC).
First Author: Christine M. Bestvina
Poster
2023 ASCO Annual Meeting
First results from the RETgistry: A global consortium for the study of resistance to RET inhibition in RET-altered solid tumors.
First Author: Alissa Jamie Cooper